US OptionsDetailed Quotes
NVO241220C123000
- 0.01
- 0.000.00%
15min DelayTrading Dec 20 16:00 ET
0.00High0.00Low
0.00Open0.01Pre Close0 Volume582 Open Interest123.00Strike Price0.00Turnover0.00%IV41.52%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier-9DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma8692.00Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Novo-Nordisk A/S Stock Discussion
Sign in to post a comment
$Novo-Nordisk A/S (NVO.US)$
🔬🔬🔬👇🏻🤔
2 Pharmaceutical Growth Stocks to Buy Now and Hold for Decades | The Motley Fool
Will the medical industry still give it out? 🔮🔮🔮
Anybody with medical experience, please share.
🔬🔬🔬👇🏻🤔
2 Pharmaceutical Growth Stocks to Buy Now and Hold for Decades | The Motley Fool
Will the medical industry still give it out? 🔮🔮🔮
Anybody with medical experience, please share.
1
$Novo-Nordisk A/S (NVO.US)$ premarket bulltrap
3
2
Morning Movers
Gapping up
$Novo-Nordisk A/S (NVO.US)$ shares rose 5%, recovering from an 18% drop in the previous session after its weight loss drug, CagriSema, posted disappointing late-stage trial results on Friday.
$Tesla (TSLA.US)$ gained 3% premarket, recovering from last week's 3.5% drop, its worst performance since before the U.S. presidential election.
$Traws Pharma (TRAW.US)$ shares surged 109% after announcing progress on...
Gapping up
$Novo-Nordisk A/S (NVO.US)$ shares rose 5%, recovering from an 18% drop in the previous session after its weight loss drug, CagriSema, posted disappointing late-stage trial results on Friday.
$Tesla (TSLA.US)$ gained 3% premarket, recovering from last week's 3.5% drop, its worst performance since before the U.S. presidential election.
$Traws Pharma (TRAW.US)$ shares surged 109% after announcing progress on...
25
1
14
$Novo-Nordisk A/S (NVO.US)$ Statistics are always open to interpretation. Never a 100 percent correct evaluation. In doing so, Novo also point out a number of RESEARCH LIMITATIONS. Less than SIX out of TEN obese patients would have used the highest permitted dose. Nevertheless, Novo Nordisk will ask the regulators of the pharmaceutical industry to allow the drug for commercialization.
So, would you care if a weight loss supplement only achieved a 22.7% weight ...
So, would you care if a weight loss supplement only achieved a 22.7% weight ...
$Novo-Nordisk A/S (NVO.US)$ 150 by this year
4
1
$Novo-Nordisk A/S (NVO.US)$ why the drop
1
1
$Novo-Nordisk A/S (NVO.US)$ Waoooo so cheapp now
1
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
$Novo-Nordisk A/S (NVO.US)$
no idea whats up w/ nvo for entry but nvox is a new leaveraged ticker. it just started recently so hadn't had a chance to go up yet before tanking. this is the complete history of ticker.
$Defiance Daily Target 2X Long NVO ETF (NVOX.US)$
no idea whats up w/ nvo for entry but nvox is a new leaveraged ticker. it just started recently so hadn't had a chance to go up yet before tanking. this is the complete history of ticker.
$Defiance Daily Target 2X Long NVO ETF (NVOX.US)$
7
No comment yet
Money Thrill : Not a problem... between 80 and 90 good price. You can never trust statistics 100%. There is always a margin of error. For example, the patients did not take the prescribed maximum dose. And 2 % difference is negligible. Exaggerated price reaction. I will definitely buy some more ... next days or week .